Stay updated on Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page
- Check5 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; Back to Top was removed, indicating a minor UI change with no substantive content changes.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical topics related to colorectal cancer and specific compounds. Notably, the previous version's details about azacitidine and various antineoplastic agents have been removed.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.